ABSTRACT
INTRODUCTION
Thrombosis is a serious pathological issue that causes high rates of morbidity and mortality. 1 Thrombus formed in the circulatory system due to loss of homeostasis can cause vascular blockage, atherothrombotic diseases, myocardial or cerebral necrosis that will lead to death. 2 Despite being essential to maintaining the vascular integrity and bleeding through blood clot formation, platelets are also implicated in the pathological progression of arterial vascular thrombosis. The pathological mechanisms are through their adherence to the sites of injured vessel tissue, an aggregation to a plug forming, and accelerating coagulation cascades. 3, 4 Inhibiting the platelet aggregation is one of the mechanisms to prevent cardiovascular disease that reported as number one cause of death. 1 Aspirin has been widely used as an antiplatelet agent and in the prevention of atherosclerotic event. 5 However, the previous study reported that some patients have resistance to aspirin, resulting in poor therapy result. 6 Thus, some studies have been conducted to discover antithrombotic agents from a medicinal plant. Mucuna pruriens (MP) L. and Coriandrum sativum (CS) are widely used in Indonesia as food, spice, and kitchen herb. Besides that, both plants had been found for some medicinal properties including in antithrombotic activity. Previous studies showed that MP L. extract could prevent thrombosis with its antithrombotic activity in hypercholesterolemic rat 7 and inhibit the adenosine diphosphate-induced human platelet aggregation. 8 Another study reported that the total polyphenolic content of MP methanol extract has high antioxidant activity. 9 Furthermore, the herb part of CS contains rutin which had been found to possess antiplatelet activity by inhibiting ion Ca 2+ mobilization and thromboxane A2 (TXA2) formation. 10, 11 Supported by literature data, this study aimed to further investigate the antiplatelet and antithrombotic activities of MP L. and CS. Antithrombotic activity in this study was examined by measuring the bleeding time and survival rate.
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MATERIALS AND METHODS
Chemicals and plant materials
Epinephrine was obtained from Sigma-Aldrich (Nucleos, Singapore) and carboxymethylcellulose (CMC) was from Brataco (Jakarta, Indonesia). Aspirin, collagen, and other chemical reagents were purchased from Sigma-Aldrich (Tokyo, Japan). Phytochemical screening Phytochemical screening was done to identify the presence of metabolite and biologically active compounds in the plant extracts. The screening for identification of alkaloids, saponins, tannins, flavonoids, terpenoids, and glycosides was performed using standard procedures. 13, 14 Total flavonoid and phenolic contents Total flavonoid content was determined by making a working solution at first. Plant extract equivalent to 200 mg of aqueous extract was added 1 mL of 0.5% hexamethylenetetramine, 20 mL of acetone, and 2 mL of 25% HCl. The suspension was then refluxed for 30 min and filtered. After that, 20 mL of filtrate was extracted with ethyl acetate three times, and the ethyl acetate fraction was collected as a working solution. Blank solution was made by adding glacial acetic acid into 10 mL of working solution. The sample solution was prepared by adding 1 mL of 2% aluminum trichloride and glacial acetic acid to 10 mL of working solution. The total phenolic content was determined by Folin-Ciocalteu test and was measured in λ = 725 nm.
Experimental animals
This study used male DDY strain mice (Mus musculus) weighing 20-30 g from Faculty of Veterinary, Bogor Agriculture Institute. All mice were allowed free access to food and water and housed in 12 h light-dark periods. The acclimatization was done for 2 weeks before the experiments. This study was approved by The Ethics Committee of Faculty of Medicine, Universitas Indonesia (No. 232/UN2.F1/ETIK/2017).
Animal treatment
This study was conducted by in vivo experimental with parameters of bleeding time and survival rate. Bleeding time was determined by tail bleeding assay which uses a total of 25 DDY mouse for each plant extract that was divided randomly into five groups of five animals as follow: Survival rate test was done by dividing randomly into six groups of five animals: normal control, positive control, negative control, and three sample groups in different doses for each plant extract. Animals were treated both in bleeding time and survival tests orally (0.3 mL/20 g BW/ mice/day) with the corresponding agents for 7 d.
Tail bleeding assay
On the last day of treatment, after 5 h of administration, animals were anesthetized. The tail was cut 10 mm from the tip by and immediately immersed into isotonic saline solution inside a tube. Each mouse was observed for 20 min to determine the bleeding time. The experiment will be stopped after 20 min to prevent the death of experimental animals. 15 
Pulmonary thromboembolism model
Survival rate was determined by using pulmonary thromboembolism model in experimental mice as described by Saputri et al., with a slight modification. 16 After 24 h of the last administration, experimental animals (positive, negative, D1, D2, and D3 groups) were injected with collagen-epinephrine (700 μg: 42 μg) solution to induce thrombosis while the normal control group was given an injection of isotonic saline solution. The observation was done for 15 min to determine the total lethal or paralyzed effects. Efficacy percentage of the three extracts was obtained by comparing to the normal control group, and the survival rate (%) was calculated with the formulation:
Statistical analysis
The obtained data were processed statistically. Homogeneity of data was determined with Levene test, and the normality of data was analyzed with the Shapiro-Wilk test. One-way ANOVA test was performed and the relation between each treatment group was observed by the least significant difference test. P < 0.05 was considered to be statistically significant.
RESULTS
Phytochemical screening
The phytochemical screening results of MP and CS extract were summarized in Table 1 . It showed the presence of alkaloid, saponin, flavonoid, and glycoside in MP extract, while tannin and terpenoid were tested negative. On the other hand, CS extract was found to contain only saponin and glycoside.
Total flavonoid and phenolic contents
Total flavonoid and phenolic content of MP extract was found at 0.002% and 0.650%, respectively. On the other hand, the total flavonoid and phenolic content of CS extract were 0.439% and 0.260%, respectively.
Bleeding time
Compared to the normal control group, 7 days of treatment with MP and CS extract increased the bleeding time in mice. As shown in Table 2 , the bleeding time of positive control group and treated groups were significantly different from the normal control group (P < 0.05). This study demonstrated that the highest mean value of bleeding time was shown by MP D2 group (17.61 ± 3.02). Figure 1 shows that all doses of 
Survival rate
Compared to the negative control group, 7 days of treatment with MP and CS extracts increased the survival rate in treated groups. As shown in Table 3 , the highest survival rate was demonstrated by CS D1 (80%) with the dose given of 1.5 mg/20 g body weight (BW).
DISCUSSION
Beside the function of platelets in the human primary hemostatic mechanism that essential in the control of bleeding through forming blood clot, they are also contributed to the atherosclerosis progression and arterial vascular thrombosis. [17] [18] [19] [20] It is important to evaluate the function of platelet to developing the antithrombotic agent and preventing the prevalence of cardiovascular disease. This study was conducted to find the in vivo effect of MP L. and CS as the antithrombotic agent.
This in vivo study showed the antithrombotic effect of MP L. and CS administered orally in mouse thrombotic model by conducting bleeding time and survival rate tests. MP L. extract exerts the increase of bleeding time longer than positive group (aspirin) compared to normal group. Genistein contained in MP inhibited platelet activation and aggregation by receptor TXA2 mechanism. 7, 21 By inhibiting TXA2 receptors, protein kinase C activation will be inhibited, and ion Ca 2+ decreased which further inhibit platelet activation. Inhibition of platelet activation and aggregation can prevent the formation of thrombus. Thus, make the blood flow run smoothly. In MP group, D1 and D2 are in a dose-dependent manner, but the bleeding time is decreasing in D3 group even though it is still significantly different with the normal group. It may be due to D3 was not included in the optimum dose range of MP as an antithrombotic agent. Aqueous MP extract reported having optimum dose 500 mg/200 g in the previous study with hypercholesterolemia rats. 7 CS extract significantly increased bleeding time in mice compared to the normal group. It was reported that CS contains polyphenols constituent that inhibits platelet activation and aggregation through inhibition of ion Ca 2+ mobilization. 10, 22 The inhibition of ion Ca 2+ mobilization further inhibits platelet activation resulting in thinner blood consistency. Rutin contained in CS extract possess inhibitor activity on platelet aggregation by inhibiting platelet phospholipase C. 21, 23 For survival rate test, the collagen-epinephrine combination was used in this study as thrombosis inducer. Collagen has a major role as platelet activator after damage to vessel tissue. Collagen induces TXA and inositol production which later induces Ca 2+ mobilization. Then, Ca 2+ mobilization activates platelet that signed with shape change, granule secretion, and aggregation. 24 The highest number of survival rate was shown by CS D1 (80%). In MP group, D1 and D2 are in a dose-dependent manner, but the survival rate is decreasing in D3 group even though it is still significantly different with the normal group. It may be due to D3 was not included in the optimum dose range of MP as an antithrombotic agent. The previous study about genistein as antiplatelet showed that the effectivity of genistein against collagen depends on the collagen concentration. The effect from genistein with a concentration of 30 and 100 μM can inhibit collagen-induced thrombosis with collagen concentration 1 μg/ml. 25 Even if there is inhibitory activity in lower or higher dose, the result is not as good as in optimum dose. In CS-treated group showed the increasing of bleeding time in three given dose, but there is a decrease in D2 and D3 group which survival rate is 40%. The decrease of survival rate may be due to D2 and D3 was not included in an optimum dose range of CS as platelet activation inhibitor that induced by collagen. In previous in vitro study has reported that CS leaves have an optimum dose at 1.1 mg/mL to inhibit 0.005% collagen. 
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